大脑天然尿素和血液透析治疗患者的全因死亡率
Maria K Svensson1,2, Rita Nassar1, Jan Melin1
1Department of Medical Sciences, Renal Medicine, Uppsala University Hospital, Akademiska sjukhuset, Entrance 40, floor 5, Uppsala, SE, 751 85, Sweden.
BMC nephrology
|June 23, 2025
概括
脑性尿素 (BNP) 与血液透析的慢性病 (CKD) 患者的死亡率相关. 然而,年龄,炎症和手握强度是比BNP更重要的死亡率预测因素.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 生物化学 生化学
背景情况:
- 脑性尿素 (BNP) 是一种由心脏释放的激素,以应对液体过载.
- 在慢性病 (CKD) 患者接受血液透析,流体过载和过 (OH) 是显著的死亡风险.
- 这项研究探讨了BNP,OH和血液透析中CKD患者的死亡率之间的关系.
研究的目的:
- 调查血液透析中慢性病患者BNP水平与全因死亡率之间的关联.
- 为了确定过度水分 (OH) 是否是这个患者群的死亡率的一个重要因素.
- 确定在接受血液透析的CKD患者中死亡的关键临床和生化预测因素.
主要方法:
- 一项前性观察性研究,分析了64名接受血液透析的CKD患者的5年生存率.
- 两变相关性分析,以评估BNP,OH和全因死亡率之间的关系.
- 考克斯回归分析以调整影响NP-死亡率关系的临床和生化因素.
主要成果:
- 在为期五年的研究期间,52%的患者死亡.
- BNP,年龄,手握强度,瘦组织指数和CRP水平最初与全因死亡率有关.
- 在对共变量进行调整后,年龄,手握强度和CRP成为死亡率的独立预测指标,而BNP没有.
结论:
- 在接受血液透析的CKD患者中,BNP与全因死亡率有相关性,但OH没有.
- 年龄,炎症 (CRP) 和手握强度被确定为比BNP更重要的死亡率独立预测因素.
- 这些发现表明,在接受血液透析的CKD患者中,应关注这些临床因素来分层风险.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
223
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
223
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524
Hormonal Regulation of Blood Pressure
3.2K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.2K
Antihypertensive Drugs: Action of β1 Blockers
635
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
635
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
911
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
911
Hemodialysis III: Nursing Management
215
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
215


